Pricing Log in Create free account

Autolus Therapeutics PLC Sponsored ADR (AUTL) vs TRex Bio Inc. (TRXB)

Autolus Therapeutics PLC Sponsored ADR and TRex Bio Inc. are both Biotechnology companies. Autolus Therapeutics PLC Sponsored ADR and TRex Bio Inc. are of similar size ($376.8M and $376.6M).

Valuation

Metric AUTL TRXB Biotechnology median
P/E n/m — 10.64
P/S 3.22 — 9.59
P/B 5.05 — 2.15
Price to free cash flow n/m — 26.07
EV/EBITDA n/m — 0.65
EV/Sales 2.15 — 9.45
Earnings yield (74.65%) — (34.69%)
Free cash flow yield (67.18%) — (24.02%)

Profitability

Metric AUTL TRXB Biotechnology median
Gross margin 15.66% — 65.59%
Operating margin (210.78%) — 0.00%
Net margin (238.66%) — 0.00%
Free cash flow margin (198.26%) — 0.00%
Return on equity (133.00%) — (51.96%)
Return on assets (46.15%) — (46.06%)
Return on invested capital 0.00% — 0.00%

Growth

Metric AUTL TRXB Biotechnology median
Revenue growth (TTM) 193.29% — 4.59%
EPS growth (last fiscal year) (25.58%) — 29.88%
Revenue growth, 5-year CAGR 113.11% — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric AUTL TRXB Biotechnology median
Debt to equity 1.04 — 0.00
Current ratio 4.89 — 4.86
Net debt to EBITDA 1.16 — 1.01

Dividend

Metric AUTL TRXB Biotechnology median
Dividend yield — — 0.38%
Payout ratio — — —

Size

Metric AUTL TRXB Biotechnology median
Market cap 376.62m 376.83m 174.29m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack